Order Article Reprints

Hörmann AA, Klingler M, Rangger C, Mair C, Decristoforo C, Uprimny C, Virgolini IJ, von Guggenberg E. Radiopharmaceutical Formulation and Preclinical Testing of ⁶⁸Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial. Pharmaceuticals. 2021; 14(6):575. https://doi.org/10.3390/ph14060575

Hörmann, Anton A., Maximilian Klingler, Christine Rangger, Christian Mair, Clemens Decristoforo, Christian Uprimny, Irene J. Virgolini, and Elisabeth von Guggenberg. 2021. "Radiopharmaceutical Formulation and Preclinical Testing of ⁶⁸Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial" Pharmaceuticals 14, no. 6: 575. https://doi.org/10.3390/ph14060575

Hörmann, A. A., Klingler, M., Rangger, C., Mair, C., Decristoforo, C., Uprimny, C., Virgolini, I. J., & von Guggenberg, E. (2021). Radiopharmaceutical Formulation and Preclinical Testing of ⁶⁸Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial. Pharmaceuticals, 14(6), 575. https://doi.org/10.3390/ph14060575